MicroStrategy
MSTR
英伟达
NVDA
Adobe
ADBE
赛富时
CRM
苹果
AAPL
美股市场个股详情
ITCI Intra-Cellular Therapies
- 83.450
- -0.690-0.82%
收盘价 12/20 16:00 (美东)
- 83.450
- 0.0000.00%
盘后 20:01 (美东)
88.47亿总市值-95.92市盈率TTM
85.030最高价82.760最低价112.05万股成交量84.540今开84.140昨收9387.17万成交额1.08%换手率亏损市盈率(静)1.06亿总股本93.45052周最高7.73市净率86.57亿流通值62.78052周最低--股息TTM1.04亿流通股93.450历史最高--股息率TTM2.70%振幅6.750历史最低83.779平均价1股每手
Intra-Cellular Therapies所有资讯
Intra-Cellular Therapies | 4：持股变动声明-高管 Mates Sharon
Intra-Cellular Therapies | 4：持股变动声明-高管 Halstead Michael
Intra-Cellular Therapies | SC 13G/A：超过5%持股股东披露文件(修正)-FMR LLC(10.525%),Abigail P. Johnson(10.525%)
Intra-Cellular Therapies | SC 13G/A：超过5%持股股东披露文件(修正)-BlackRock, Inc.(5.9%)
Intra-Cellular Therapies | SC 13G/A：超过5%持股股东披露文件(修正)-BlackRock, Inc.(5.9%)
Intra-Cellular Therapies | 4：持股变动声明-董事 RIGGS RORY B
Intra-Cellular Therapies | SC 13G：超过5%持股股东披露文件-JPMORGAN CHASE & CO.(5.0%)
Intra-Cellular Therapies | 4：持股变动声明-董事 RIGGS RORY B
Intra-Cellular Therapies | 4：持股变动声明-高管 Mates Sharon
Intra-Cellular Therapies | 4：持股变动声明-高管 Mates Sharon
Intra-Cellular Therapies | 4：持股变动声明-高管 Mates Sharon
Intra-Cellular Therapies | 4：持股变动声明-高管 Neumann Mark
Intra-Cellular Therapies | 4：持股变动声明-高管 Narula Sanjeev
Intra-Cellular Therapies | 3：首次持股声明-高管 Narula Sanjeev
Intra-Cellular Therapies | 4：持股变动声明-董事 VAN NOSTRAND ROBERT L
Intra-Cellular Therapies | 4：持股变动声明-董事 RIGGS RORY B
Intra-Cellular Therapies | 4：持股变动声明-董事 VAN NOSTRAND ROBERT L
Intra-Cellular Therapies | 4：持股变动声明-董事 Salas Eduardo Rene
Intra-Cellular Therapies | 4：持股变动声明-董事 MARCUS JOEL S
Intra-Cellular Therapies | 4：持股变动声明-董事 RIGGS RORY B